Ph.D., CSO, Affini-T Therapeutics
Biography
Loïc Vincent, PhD, is CSO at Affini-T Therapeutics. He is an oncology scientist with 20+ years’ international experience in academia / biotech / pharma industry, dedicated to advancing transformative therapies to patients suffering from cancer. Previously, Loïc was the Head of Takeda Oncology Drug Discovery Unit and Immunology Unit, and was responsible for leading Takeda Cell Therapy Discovery. Prior to joining Takeda in 2016, Loïc spent nine years at Sanofi, where he led Oncology Drug Discovery Pharmacology, Immunotherapy and Oncology External Innovation teams. Loïc is a former board member of the French-American Biotechnology Springboard and former Board Director at Adaptate Biotherapeutics. During his career, Loïc’s teams advanced more than 20 oncology drugs in the clinic.Loïc obtained his PhD in pharmacology from the University of Rouen, France. He carried out his postdoctoral fellowship in oncology at the Weill Medical College of Cornell University, NY.
Session Abstract – PMWC 2023 Silicon Valley
Track 1 - January 26 9.00 A.M.-4.30 P.M.
Track Chair: Sharon Benzeno, Adaptive Biotechnologies
- PMWC 2023 Luminary Award Ceremony
Honoree: Bruce Levine, University of Pennsylvania
- Advance and Optimize Cell Therapies in Oncology (PANEL)
Chair: Sharon Benzeno, Adaptive Biotechnologies
- Ira Mellman, Genenetch
- Mark Selby, Walking Fish Therapeutics
- Sneha Ramakrishna, Stanford
- Loïc VINCENT, Affini-T Therapeutics
- Nick Haining, Arsenal
- Warner Biddle, Kite - Pioneering Cell Therapies in the Treatment of Autoimmune Disorders (PANEL)
Chair: Carl June, UPenn
- Lenny Dragone, Sonoma
- James Chung, Kyverna
- David Chang, Cabaletta
- Cristina Musselli, Abata Therapeutics - Innovations in Cell Therapy Manufacturing (PANEL)
Chair: Bruce Levine, University of Pennsylvania
- Chris Holt, BMS
- Heidi Hagen, Sonoma Bio
- Rahul Singhvi, Resilience
- Snehal Patel, Sana Biotechnology - Patentability of Immunotherapies - Latest Developments
- Janet Xiao, Morrison & Foerster LLP
- Investing in Gene-Modified Cell Therapies
Chair: Karen Tkach Tuzman, BioCentury Inc.
- Robert Lin, UPMC
- Yvonne Yamanaka, venBio
- Abraham Bassan, Samsara Capital
- Brian Daniels, 5am Ventures
- Leveraging Data Sets to Inform Future Drug Discovery and Development (PANEL)
Chair: Jason Coloma, Maze Therapeutics
- Peter DiLaura, Sonoma Bio
- Nick Haining, Arsenal
- Kwame Okrah, Parker Institute
- Dan Kirouac, Notch Therapeutics
